- Home
- NAGE vs MFA Comparison
NAGE vs MFA Comparison
Compare NAGE & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- MFA
- Stock Information
- Founded
- NAGE 1999
- MFA 1997
- Country
- NAGE United States
- MFA United States
- Employees
- NAGE N/A
- MFA N/A
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- MFA Real Estate Investment Trusts
- Sector
- NAGE Health Care
- MFA Real Estate
- Exchange
- NAGE Nasdaq
- MFA Nasdaq
- Market Cap
- NAGE 861.0M
- MFA 1.0B
- IPO Year
- NAGE N/A
- MFA N/A
- Fundamental
- Price
- NAGE $13.44
- MFA $9.47
- Analyst Decision
- NAGE Strong Buy
- MFA Buy
- Analyst Count
- NAGE 3
- MFA 6
- Target Price
- NAGE $16.67
- MFA $12.50
- AVG Volume (30 Days)
- NAGE 930.6K
- MFA 1.2M
- Earning Date
- NAGE 08-06-2025
- MFA 08-07-2025
- Dividend Yield
- NAGE N/A
- MFA 15.17%
- EPS Growth
- NAGE N/A
- MFA N/A
- EPS
- NAGE 0.18
- MFA 0.99
- Revenue
- NAGE $107,925,000.00
- MFA $292,245,000.00
- Revenue This Year
- NAGE $26.21
- MFA N/A
- Revenue Next Year
- NAGE $20.91
- MFA $14.73
- P/E Ratio
- NAGE $75.10
- MFA $9.58
- Revenue Growth
- NAGE 29.77
- MFA 52.95
- 52 Week Low
- NAGE $2.31
- MFA $7.85
- 52 Week High
- NAGE $14.49
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- NAGE N/A
- MFA 47.30
- Support Level
- NAGE N/A
- MFA $9.36
- Resistance Level
- NAGE N/A
- MFA $9.73
- Average True Range (ATR)
- NAGE 0.00
- MFA 0.18
- MACD
- NAGE 0.00
- MFA -0.00
- Stochastic Oscillator
- NAGE 0.00
- MFA 42.62
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.